PEPTAI an decentralized science token exploded to nearly $2.50 on Dexscreener before crashing back toward $0.9033, all while AI-driven drug discovery narratives keep heating up across the market. And honestly, it’s not hard to see why attention suddenly flooded in.
Autonomous Drug Discovery Narrative Gains Momentum
The project centers around autonomous AI agents built for peptide drug discovery. Instead of relying on the painfully slow traditional pharmaceutical pipeline, PEPTAI claims its system can design novel peptide molecules within 24 hours while handling validation through a multi-stage computational pipeline.
Well, the platform also uses blockchain infrastructure to secure intellectual property rights automatically. That’s the kind of “AI + crypto + biotech” crossover narrative it has.
coinpedia.org
